Influences of an anticholinergic antiparkinsonian drug, parkinsonism, and psychotic symptoms on cardiac autonomic function in schizophrenia

Journal of Clinical Psychopharmacology

Volumn 23, Issue 5, 2003, Pages 441-447

  Okada, Takashi ^a   Toichi, Motomi ^b   Sakihama, Morimitsu ^c  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; BIPERIDEN; CHOLINERGIC RECEPTOR BLOCKING AGENT; HALOPERIDOL; NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; HEART FUNCTION; HEART RATE VARIABILITY; HUMAN; PARKINSONISM; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; RATING SCALE; RR INTERVAL; SCHIZOPHRENIA; SYMPATHETIC FUNCTION; SYMPTOMATOLOGY; VAGUS NERVE STIMULATION; XEROSTOMIA;

ADULT; AGED; ANTIPARKINSON AGENTS; CHOLINERGIC ANTAGONISTS; FEMALE; HEART FUNCTION TESTS; HUMANS; MALE; MIDDLE AGED; PARKINSONIAN DISORDERS; PSYCHOTIC DISORDERS; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0141706753     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000088901.24613.b8     Document Type: Article

References (36)

1. Appenzeller O, Goss JE. Autonomic deficits in Parkinson's syndrome. Arch Neurol. 1971;24:50-57.
2. Goetz CG, Lutge W, Tanner CM. Autonomic dysfunction in Parkinson's disease. Neurology. 1986;36:73-75.
3. Orskov L, Jakobsen J, Dupont E, et al. Autonomic function in parkinsonian patients relates to duration of disease. Neurology. 1987;37:1173-1178.
4. Singh MM, Smith JM. Reversal of some therapeutic effects of an antiparkinsonism drug. J Nerv Ment Dis. 1973;157:50-58.
5. Singh MM, Kay SR. Therapeutic antagonism between neuroleptics and anticholinergic antiparkinsonian agents in schizophrenia. J Bronx State Hosp. 1974;2:8-20.
6. Singh MM, Kay SR. Therapeutic reversal with benztropine in schizophrenics: practical and theoretical significance. J Nerv Ment Dis. 1975;160:258-266.
7. Jellinek T, Gardos G, Cole JO. Adverse effects of antiparkinson drug withdrawal. Am J Psychiatry. 1981;138:1567-1571.
8. Toichi M, Kubota Y, Murai T, et al. The influence of psychotic states on the autonomic nervous system in schizophrenia. Int J Psychophysiol. 1999;31:147-154.
9. Chouinard G, Annable L, Ross-Chouinard A, et al. Ethopropazine and benztropine in neuroleptic-induced parkinsonism. J Clin Psychiatry. 1979;40:147-152.
10. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261-276.
11. Lorenz EN. Deterministic nonperiodic flow. J Atmos Sci. 1963;20:130-141.
12. Toichi M, Sugiura T, Murai T, et al. A new method of assessing cardiac autonomic function and its comparison with spectral analysis and coefficient of variation of R-R interval. J Auton Nerv Syst. 1997;62:79-84.
13. Cooley JW, Tukey JW. An algorithm for the machine calculation of complex Fourier series. Math Comput. 1965;19:297-301.
14. Zahn TP, Carpenter WT Jr, McGlashman TH. Autonomic nervous system activity in acute schizophrenia: method and comparison with normal controls. Arch Gen Psychiatry. 1981;38:251-258.
15. Dawson ME, Nuechterlein KH, Schell AM, et al. Autonomic abnormalities in schizophrenia: state or trait indicators? Arch Gen Psychiatry. 1994;51:813-824.
16. Rechlin T, Claus D, Weis M. Heart rate variability in schizophrenic patients and changes of autonomic heart rate parameters during treatment with clozapine. Biol Psychiatry. 1994;35:888-892.
17. Kuroiwa Y, Shimada Y, Toyokura Y. Postural hypotension and low R-R interval variability in Parkinson, spino-cerebellar degeneration, and Shy-Drager syndrome. Neurology. 1983;33:463-467.
18. Kuroiwa Y, Wada T, Tohgi H. Measurement of blood pressure and heart-rate variation while resting supine and standing for the evaluation of autonomic dysfunction. J Neurol. 1987;235:65-68.
19. Ferini-Strambi L, Franceschi M, Pinto P, et al. Respiration and heart rate variability during sleep in untreated Parkinson patients. Gerontology. 1987;38:92-98.
20. Wheeler T, Watkins PJ. Cardiac denervation in diabetes. Br Med J. 1973;4:584-586.
21. Murray A, Ewing DJ, Campbell IW, et al. RR interval variations in young male diabetics. Br Heart J. 1975;37:882-885.
22. Bennett T, Fentem PH, Fitton D, et al. Assessment of vagal control of the heart in diabetes: measures of R-R interval variation under different conditions. Br Heart J. 1977;39:25-28.
23. Pfeifer MA, Cook D, Brodsky J, et al. Quantitative evaluation of cardiac parasympathetic activity in normal and diabetic man. Diabetes. 1982;31:339-345.
24. Jakobsen J, Hauksson P, Vestergaad P. Heart rate variation in patients treated with antidepressants: an index of anticholinergic effects? Psychopharmacology (Berl). 1984;84:544-548.
25. Zahn TP, Pickar D. Autonomic effects of clozapine in schizophrenia: comparison with placebo and fluphenazine. Biol Psychiatry. 1993;34:3-12.
26. Sayers B McA. Analysis of heart rate variability. Ergonomics. 1973;16:17-32,
27. Pomeranz B, Macaulay JB, Caudill MA, et al. Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol. 1985;248:H151-H153.
28. Pagani M, Lombardi F, Guzzetti S, et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res. 1986;59:178-193.
29. Pagani M, Furlan R, Pizzinelli P, et al. Spectral analysis of R-R and arterial pressure variabilities to assess sympatho-vagal interaction during mental stress in humans. J Hypertens. 1989;Suppl 7:S14-S15.
30. Chess GF, Tam MK, Calaresu FR. Influence of cardiac neural inputs on rhythmic variations of heart period in the cat. Am J Physiol. 1975;228:775-780.
31. Akselrod S, Gordon D, Ubel FA, et al. Power spectrum analysis of heart rate function: a quantitative probe of beat-to-beat cardiovascular control. Science. 1981;213:220-222.
32. Raeder EA, Berger R, Kenet R. Assessment of autonomic cardiac control by power spectrum of heart rate fluctuations: effect of neural ablation and suppression of efferent sympathetic nerve traffic. J Appl Cardiol. 1987;2:283-300.
33. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Circulation. 1996;93:1043-1065.
34. Brown JH, Taylor P. Muscarinic receptor agonists and antagonists. In: Hardman JG, Limbird LE, Molinoff PB, et al, eds. The Pharmacological Basis of the Therapeutics. 9th ed. New York: McGraw-Hill; 1996:150.
35. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17:427-442.
36. Zahn TP, Jacobsen LK, Gordon CT, et al. Autonomic nervous system markers of psychopathology in childhood-onset schizophrenia. Arch Gen Psychiatry. 1997;54:904-912.